Although intratumoral injection of OAd-GFP or CD70 CAR-T cells suppressed tumor progression and prolonged mouse survival, the CAR-TOAd−GFP combination had a strong antitumor effect, leading to tumor regression and long-term survival (Fig. 2C and D, and 2E). The gene discussed is CD70; the disease is neoplasm.